Source link : https://www.newshealth.biz/health-news/t1d-stem-cell-success-story-lillys-discount-tirzepatide-vials-stelo-now-available/
A type 1 diabetes patient talked about her successful treatment with an investigational stem cell therapy currently in trials, noting that she hasn’t needed insulin since last August. (Washington Post) Eli Lilly said tirzepatide (Zepbound) single-dose vials are available for self-pay through LillyDirect, significantly expanding the supply for patients with obesity. Risk for dementia was […]
Author : News Health
Publish date : 2024-08-27 17:55:47
Copyright for syndicated content belongs to the linked Source.
Categories